| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |